by inpharmedia | Sep 3, 2022 | Guidances, Regulatory
US FDA has issued a series of guidance’s to assists the sponsor and applicant in the generic drug development. The August month has around 06 new/revised guidance under GDUFA and ICH provisions. The links of the guidance’s are provided below for quick review and... by inpharmedia | Feb 9, 2020 | Blog
Inactive Ingredient An inactive ingredient is a component of a dosage form, other than the active ingredient, which is inert material and enhances the drug properties acting as a vehicle. Inactive substance may also termed as ‘Excipient’, historically derived from...